Abstract
Purpose of Review
To review the diagnosis, surgical evaluation, surgical techniques, and outcomes of vitrectomy for tractional retinal detachments (TRDs) in patients with diabetes.
Recent Findings
Tractional retinal detachment is the leading cause of blindness in patients with diabetes. They account for 40% of all vitrectomies in patients with proliferative diabetic retinopathy. The use of small gauge microincisional vitrectomy systems, enhanced visualization, anti-VEGF, and optimized instrumentation and surgical techniques have revolutionized the treatment and outcomes of TRD repair. Although anatomical and visual acuity outcomes of TRD repair have greatly improved over the past 4 decades, further research is needed to reduce post-operative complications and improve final visual acuity.
Summary
Proper preoperative planning is essential to minimize intraoperative complications of TRD repair. Small gauge instrumentation allows for precise and controlled fibrovascular membrane removal and relief of traction, providing excellent reattachment rates and limiting post-operative complications.
Similar content being viewed by others
References
• Of importance
International Diabetes Federation. IDF Diabetes Atlas, 2 Dec 2020. https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed 15 Apr 2021.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;377(9735):124–36.
National Diabetes Statistics Report 2020: Estimates of diabetes and its burden in the United States. CDC. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed 7 Dec 2020.
Shani M, Eviatar T, Komaneshter D, Vinker S. Diabetic retinopathy -incidence and risk factors in a community setting- a longitudinal study. Scand J Prim Health Care. 2018;36(3):237–41.
Stewart MW, Browning DJ, Landers MB. Current management of diabetic tractional retinal detachments. Indian J Ophthalmol. 2018;66(12):1751–62.
Rice TA, Michels RG, Rice EF. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983;95(1):22–33. https://doi.org/10.1016/0002-9394(83)90330-6.
Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009;116:927–38.
Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(2):213–6.
Arevalo JF, Sanchez JG, Saldarriaga L, et al. Retinal detachment after bevacizumab. Ophthalmology. 2011;118(11):2304.e3-7.
Treumer F, Bunse A, Rudolf M, Roider J. Pars plana vitrectomy, phacoemulsification and intraocular lens implantation: comparison of clinical complications in a combined versus two-step surgical approach. Graefes Arch Clin Exp Ophthalmol. 2006;244(7):808–15.
Khan MA, Shahlaee A, Toussaint B, et al. Outcomes of 27 gauge microincision vitrectomy surgery for posterior segment disease. Am J Ophthalmol. 2016;1(161):36–43.
Berrocal MH. All-probe vitrectomy dissection techniques for diabetic tractional retinal detachments: lift and shave. Retina. 2017. https://doi.org/10.1097/IAE.0000000000001884.
Charles S, Flinn CE. The natural history of diabetic extramacular traction retinal detachment. Arch Ophthalmol. 1981;99(1):66–8.
• Khan MA, Kuley A, Riemann CD, et al. Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease. Ophthalmology. 2018;125(3):423–43. Multicenter retrospective study that demonstrated the favorable safety profile of 27g vitrectomy for posterior segment disease.
Schrey S, Krepler K, Wedrich A. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina. 2006;26(2):149–52.
Diabetic Retinopathy Vitrectomy Study Research Group. Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management: diabetic retinopathy vitrectomy study report #1. Ophthalmology. 1985;92:492–502.
Pokroy R, Desai U, Du E, et al. Bevacizumab prior to vitrectomy for diabetic traction retinal detachment. Eye. 2011;25:989–97.
Issa SA, Connor A, Habib M, Steel DH. Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5:109–14.
Dikopf M, Patel K, Setlur V, et al. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye. 2015;29:1213–9.
• Sokol JT, Schechet SA, Rosen DT, Ferenchak K, Dawood S, Skondra D. Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system. PLoS One. 2019;14(8):e0220726. Retrospective study that demonstrated favorable anatomical and visual outcomes following small gauge vitrectomy surgery for complex tractional retinal detachments.
Shroff CM, Gupta C, Shroff D, Atri N, Gupta P, Dutta R. Bimanual microincision vitreous surgery for severe proliferative diabetic retinopathy: outcome in more than 300 eyes. Retina. 2018;38(Suppl 1):S134–45.
Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(3):365–8.
Sternfeld A, Axer-Siegel R, Stiebel-Kalish H, Weinberger D, Ehrlich R. Advantages of diabetic tractional retinal detachment repair. Clin Ophthalmol. 2015;23(9):1989–94.
Abdelhadi AM, Helaly HA, Abuelkeir A. Evaluation of retinal detachment after diabetic vitrectomy: causes and ways of management. Clin Ophthalmol. 2020;14:53–60.
Gupta B, Wong R, Sivaprasad S, Williamson TH. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye. 2012;26(4):576–82.
Moore JK, Kitchens JW, Smiddy WE, et al. Retinal breaks observed during pars plana vitrectomy. Am J Ophthalmol. 2007;144(1):32–6.
Schoenberger SD, Miller DM, Riemann CD, et al. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging. 2011;42(6):474–80.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
AMB: Consultant for Alcon, DORC, Allergan, Bayer, Visionex, Oculus, AGTC, PROQR, Aerie, Regenxbio, and Novartis. MHB: Consultant for Alcon, Allergan. The following authors have no relevant financial disclosures: LAB.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical collection on Ophthalmologic Surgery.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Acaba-Berrocal, L., Berrocal, A.M. & Berrocal, M.H. Approaches to the Repair of Diabetic Traction Retinal Detachments. Curr Surg Rep 10, 218–222 (2022). https://doi.org/10.1007/s40137-022-00329-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40137-022-00329-6